Skip to search formSkip to main contentSkip to account menu

KO 286011

Known as: KO-286011 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Phospholipid EthersPyridinium Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Inhibition of PAF‐induced tPA Release by KO‐286011
Earlier studies have shown that DMAP-ethyl-PAF (KO-286 001, l-O-hexadecyl-20-ethyl-rac-glycero-3-phosphoric acid 4(N,N… 
1991
1991
Effects of the synthetic ether phospholipid KO-286011 on cells and components of rabbit blood.
The ether phospholipid KO-286011, which is related to platelet-activating factor (PAF), was examined for PAF-antagonistic action… 
1990
1990
Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo
SummaryA newly synthesised structural analogue of PAF, coded KO-286011 (1-O-hexadecyl-2-O-ethyl-racglycero-3-phosphoric acid 4-(N… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)